Bayer Fights En Banc Review Of Dow's $455M Patent Loss
Bayer urged the Federal Circuit on Tuesday to deny Dow's request for en banc rehearing of a ruling that upheld a $455 million arbitration award against Dow for infringing Bayer's weed...To view the full article, register now.
Already a subscriber? Click here to view full article